Vivos Therapeutics Inc. shares jumped more than 270% Wednesday after the medical-device maker got regulatory clearance for removable oral appliances that treat obstructive sleepapnea. The U.S ...
Vivos Therapeutics shares rose on Wednesday after the company said its oral medical device for pediatric sleepapnea and snoring received 510(k) clearance from the Food and Drug Administration.
The gross proceeds to the Company from the offering are expected to be approximately $4.3 million, before deducting the placement agent's fees and other offering expenses payable by the Company. The ...
Vivos Therapeutics (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related ...
Vivos is poised to disrupt the very significant pediatric obstructive sleepapnea (OSA) market with new FDA clearance and new strategic marketing and distribution model Vivos' DNA appliance ...
Results that may be inaccessible to you are currently showing.